.webp){kind=small}
Culmination Bio harnesses data to influence precision medicine
Culmination Bio, a prominent biotech company, strategically harnesses longitudinal comprehensive datasets across the patient journey. Their purpose is to pioneer the creation of groundbreaking diagnostic tests, facilitate the implementation of cutting-edge therapeutic solutions, and deliver care process models. Furthermore, they seek to provide clinical insights, pinpoint therapeutic targets, and formulate meticulous care process models.
The company's mission is to help drive progress in precision medicine for healthcare. Over the course of its operation, the organization has refined an extensive repository of data, totaling hundreds of gigabytes. This remarkable collection spans a quarter-century of patient history. The datasets covered geographic distribution, diagnoses, prescribed medications, procedures undergone, laboratory results, allergies, and even genomic information. The problem? The customer had all of this data but no way to display it.
North Labs was brought in to help accelerate the capabilities of the customer’s large, complex volume of data. Amazon QuickSight was selected for a multitude of reasons. The customer had their data in Amazon S3 and Athena which would allow for ease of ingestion. Amazon QuickSight’s in-memory engine, SPICE, responds with remarkable speed and QuickSight offers interactive dashboards, embedded analytics, and natural language queries.
Upon initiation, North Labs seamlessly adapted to the evolving contours of the project's scope, progressively aligning with the expanding vision as the engagement unfolded. Ultimately, this synergy enabled the biotech enterprise to demonstrate both the depth of their data, and the kinds of insights that piqued the interest of pharmaceutical firms and researchers. Through this collaboration, the client was adept at pinpointing opportunities for advancing healthcare and medicine, thus solidifying their pivotal role in the industry's progress. The company’s SVP of Data stated, “North Labs has been a reliable and competent partner for using AWS QuickSight.”
The promise of precision medicine is great and beginning to see that promise realized through the work of this company is exciting both as an observer and for all future healthcare patients. Having better visibility and access to their data accelerated the progress and understanding of the performance of diagnostics and therapeutics.
Culmination Bio, a prominent biotech company, strategically harnesses longitudinal comprehensive datasets across the patient journey. Their purpose is to pioneer the creation of groundbreaking diagnostic tests, facilitate the implementation of cutting-edge therapeutic solutions, and deliver care process models. Furthermore, they seek to provide clinical insights, pinpoint therapeutic targets, and formulate meticulous care process models.
The company's mission is to help drive progress in precision medicine for healthcare. Over the course of its operation, the organization has refined an extensive repository of data, totaling hundreds of gigabytes. This remarkable collection spans a quarter-century of patient history. The datasets covered geographic distribution, diagnoses, prescribed medications, procedures undergone, laboratory results, allergies, and even genomic information. The problem? The customer had all of this data but no way to display it.
North Labs was brought in to help accelerate the capabilities of the customer’s large, complex volume of data. Amazon QuickSight was selected for a multitude of reasons. The customer had their data in Amazon S3 and Athena which would allow for ease of ingestion. Amazon QuickSight’s in-memory engine, SPICE, responds with remarkable speed and QuickSight offers interactive dashboards, embedded analytics, and natural language queries.
Upon initiation, North Labs seamlessly adapted to the evolving contours of the project's scope, progressively aligning with the expanding vision as the engagement unfolded. Ultimately, this synergy enabled the biotech enterprise to demonstrate both the depth of their data, and the kinds of insights that piqued the interest of pharmaceutical firms and researchers. Through this collaboration, the client was adept at pinpointing opportunities for advancing healthcare and medicine, thus solidifying their pivotal role in the industry's progress. The company’s SVP of Data stated, “North Labs has been a reliable and competent partner for using AWS QuickSight.”
The promise of precision medicine is great and beginning to see that promise realized through the work of this company is exciting both as an observer and for all future healthcare patients. Having better visibility and access to their data accelerated the progress and understanding of the performance of diagnostics and therapeutics.
Business Impact
.jpg)
